HbSC vs HbSS Sickle Cell: What's the Difference?

Hemoglobin SC disease (HbSC) and sickle cell anemia (HbSS) are both forms of sickle cell disease, but they are genetically different and affect the body in distinct ways ^[1]. The primary difference lies in the genes you inherit: in HbSS, you inherit two sickle hemoglobin genes, whereas in HbSC, you inherit one sickle hemoglobin gene and one Hemoglobin C gene ^[1]. While HbSC is generally considered a “milder” form of sickle cell disease because it typically causes fewer pain crises and hospitalizations ^[2][3], it is not a harmless condition ^[4]. People with HbSC face significant, unique risks, including late-onset spleen issues, severe bone damage, and a notably higher risk for vision-threatening eye complications than those with HbSS ^[5][6].

Understanding the Genetic Difference

To understand how these conditions differ, it helps to look at how hemoglobin—the protein in your red blood cells that carries oxygen—is inherited.

• HbSS (Sickle Cell Anemia): This is the most common and typically the most severe form of the disease. It occurs when a child inherits two sickle hemoglobin genes (one from each parent) ^[1].
• HbSC Disease: This occurs when a child inherits one sickle hemoglobin gene (HbS) from one parent and one Hemoglobin C gene (HbC) from the other ^[1].

Because individuals with HbSC have one Hemoglobin C gene (which causes red blood cells to be slightly abnormal but not severely sickle-shaped on its own) and only one sickle gene, their disease behaves differently. In regions with universal newborn screening programs, both HbSS and HbSC are diagnosed at birth ^[7]. However, while HbSS often causes severe symptoms in infancy, the symptoms of HbSC may not appear until late childhood or early adulthood ^[8].

Quick Comparison: HbSS vs. HbSC

How Symptoms and Risks Compare

While both conditions involve red blood cells changing shape and blocking blood flow, the specific complications you face depend heavily on your genotype ^[9][10].

Pain Crises and Daily Life

In general, people with HbSC experience fewer severe vaso-occlusive crises (pain episodes caused by blocked blood vessels) than people with HbSS ^[2]. Because they tend to have higher overall hemoglobin levels and milder anemia, people with HbSC often have more energy day-to-day and are hospitalized less frequently ^[11][3].

However, “milder” does not mean symptom-free. The higher hemoglobin levels in HbSC mean the blood has a higher viscosity (thickness), which can slow down blood flow and still cause severe blockages ^[12][13]. This higher viscosity also makes certain physiological states, such as pregnancy, particularly high-risk for complications like blood clots or worsening vision issues ^[14].

The Spleen: A Critical Difference

One of the most important differences between HbSS and HbSC involves the spleen. In HbSS, severe sickling usually causes the spleen to become damaged and stop working (auto-infarction) in early childhood ^[15].

Because HbSC is milder, patients typically retain their spleen function much longer—well into older childhood or adulthood ^[16]. This puts individuals with HbSC at a unique risk for late-onset splenic sequestration ^[6]. This is a life-threatening emergency where a large amount of blood suddenly becomes trapped in the spleen, causing it to enlarge rapidly. Warning signs include sudden extreme weakness, pale lips/skin, rapid heart rate, and a visibly swollen or painful left-sided abdomen.

Bone Damage (Avascular Necrosis)

Both HbSS and HbSC carry a significant, progressive risk of avascular necrosis (also called osteonecrosis) ^[17][18]. This happens when sickled cells block the blood vessels feeding the bones, causing bone tissue to die ^[19].

• It most commonly affects the hip (femoral head) but frequently damages the shoulder (humeral head) as well ^[20][21].
• How to spot it: Unlike the sudden, full-body ache of a standard pain crisis, avascular necrosis pain is typically localized to a specific joint, is persistent, and gets noticeably worse with movement or weight-bearing. Early detection through X-rays or MRIs is critical to prevent joint collapse ^[22].

Eye Complications (Sickle Retinopathy)

This is an area where HbSC is actually more dangerous than HbSS. Patients with the HbSC genotype have a significantly higher frequency of proliferative sickle cell retinopathy (PSCR) compared to patients with HbSS ^[5].

Retinopathy occurs when the small blood vessels in the back of the eye become blocked, leading to the growth of fragile, abnormal new blood vessels ^[9]. This is largely driven by the unique “thickness” (viscosity) of the blood in HbSC disease ^[12]. If left untreated, these abnormal vessels can bleed into the eye or detach the retina, permanently threatening your vision ^[23]. Because this complication is often painless and unnoticeable until severe damage has occurred, adults with HbSC must have an annual comprehensive dilated eye exam with an ophthalmologist (a medical eye doctor), not just a standard optometrist. Seek immediate care if you notice sudden “floaters,” flashes of light, or blurred vision ^[24].

Moving Forward

Because HbSC is often labeled “mild,” patients sometimes feel caught in the middle—told they aren’t as sick as someone with HbSS, yet still experiencing significant pain, bone damage, or vision issues ^[4].

It is crucial to have a hematologist who understands the specific risks of your exact genotype. While treatments like hydroxyurea are heavily studied and standardized for HbSS, there are fewer clinical guidelines tailored specifically for HbSC ^[8][25]. Treatment for HbSC is highly individualized and may include routine monitoring, red blood cell exchange transfusions, off-label use of hydroxyurea, or in some specific cases, phlebotomy (blood removal) to lower blood viscosity ^[13][8]. Do not let the “mild” label prevent you from advocating for aggressive screening and specialized care.